Pritesh Shah

Insider Reports History

Entity
Individual
Location
C/O Novocure Inc., 20 Valley Stream Parkway, Suite 300, Malvern, PA
Signature
Steven Robbins, as attorney in fact for Pritesh, Shah
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Pritesh Shah:

Stock Role Class Num Shares Value Price $ Report Date Ownership
NovoCure Ltd Chief Growth Officer Ordinary Shares 125K $1.58M $12.65 Nov 7, 2023 Direct

Insider Reports Filed by Pritesh Shah

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NVCR NovoCure Ltd Nov 7, 2023 1 -$4.83K 4 Nov 8, 2023 Chief Growth Officer
NVCR NovoCure Ltd Sep 1, 2023 1 -$5.96K 4 Sep 5, 2023 Chief Growth Officer
NVCR NovoCure Ltd Jun 30, 2023 1 $12.9K 4 Jul 6, 2023 Chief Growth Officer
NVCR NovoCure Ltd Mar 3, 2023 3 -$1.63M 4 Mar 7, 2023 Chief Growth Officer
NVCR NovoCure Ltd Mar 2, 2023 3 -$70.5K 4 Mar 6, 2023 Chief Growth Officer
NVCR NovoCure Ltd Feb 28, 2023 3 $2.29M 4 Mar 2, 2023 Chief Growth Officer
NVCR NovoCure Ltd Jan 5, 2023 1 -$41.8K 4 Jan 9, 2023 Chief Commercial Officer
NVCR NovoCure Ltd Sep 2, 2022 1 -$21.3K 4 Sep 6, 2022 Chief Commercial Officer
NVCR NovoCure Ltd Jul 5, 2022 1 $18.4K 4 Jul 7, 2022 Chief Commercial Officer
NVCR NovoCure Ltd Mar 7, 2022 2 -$542K 4 Mar 9, 2022 Chief Commercial Officer
NVCR NovoCure Ltd Mar 3, 2022 6 $3.16M 4 Mar 7, 2022 Chief Commercial Officer
NVCR NovoCure Ltd Sep 2, 2021 4 -$91K 4 Sep 7, 2021 Chief Commercial Officer
NVCR NovoCure Ltd Aug 4, 2021 1 -$307K 4 Aug 6, 2021 Chief Commercial Officer
NVCR NovoCure Ltd Aug 3, 2021 1 -$247K 4 Aug 4, 2021 Chief Commercial Officer
NVCR NovoCure Ltd Jul 31, 2021 3 $311K 4 Mar 11, 2022 Chief Commercial Officer
NVCR NovoCure Ltd Jul 6, 2021 1 $21.1K 4 Jul 8, 2021 Chief Commercial Officer
NVCR NovoCure Ltd Jun 10, 2021 1 -$5.06M 4 Jun 11, 2021 Chief Commercial Officer